logo
  

ScanSource Q1 Profit Down

ScanSource, Inc. (SCSC) Thursday reported a slight drop in profit for the first quarter, despite higher revenues.

Greenville, South Carolina-based ScanSource's first-quarter profit dropped to $19.2 million or $0.67 per share from $19.4 million or $0.69 per share last year.

Analysts polled by Thomson Reuters expected the company to earn $0.61 per share for the quarter. Analysts' estimates typically exclude one-time items.

On an adjusted basis, earnings rose to $21.6 milion or $0.75 per share from $20.5 million or $0.73 per share last year.

Revenues for the quarter grew 8.2 percent to $791.7 million from $731.9 million a year ago. Analysts had a consensus revenue estimate of $753.0 million for the quarter.

"We achieved record quarterly sales and had double-digit growth in our Worldwide Barcode and Security segment for the second quarter in a row," said CEO Mike Baur. "International sales growth was especially strong, increasing 13% over the prior year."

Looking forward to the second quarter, the company expects adjusted earnings of $0.64 to $0.66 per share on revenues of $700 million to $800 million.

Analysts currently estimate earnings of $0.65 per share on revenues of $774.85 million for the second quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT